Key result
Clinically relevant concentrations of adrenaline (1-10 nM) significantly augmented human platelet activation, thrombus formation, and procoagulant responses in the presence of subthreshold collagen, and attenuated fibrinolysis.
Why the study?
The complex effect of clinically relevant adrenaline concentrations on thrombus formation, coagulation, and fibrinolysis in human blood had never been specifically studied.
Does adrenaline increase platelet procoagulant response and thrombus formation in human blood from healthy volunteers?
Does adrenaline increase platelet procoagulant response and thrombus formation in human blood from healthy volunteers?
Clinically relevant concentrations of adrenaline augment human platelet procoagulant responses in the presence of subthreshold collagen, suggesting a mechanism for stress- or infusion-related prothrombotic states.
Answers are grounded in this paper and cite their sources.
Adrenaline may promote stress- or infusion-related thrombosis; animal data leave open human relevance and require clinical confirmation.
Background: Adrenaline is believed to play a role in thrombosis and hemostasis. The complex effect of its clinically relevant concentrations on thrombus formation, coagulation and fibrinolysis in human blood has never been specifically studied. Methods: Confocal microscopy was used to study thrombus formation under flow, exposure of phosphatidylserine (PS) in adhered platelets, to evaluate clots density, and to measure kinetics of fibrin formation and external fibrinolysis under flow. Flow cytometry was utilized to assess PS exposure in non-adhered platelets. Kinetics of clot formation and internal fibrinolysis was evaluated by thromboelastometry. Platelet aggregation was measured by optical aggremometry. Kinetics of clot retraction was assessed by using digital camera. Results: We found that adrenaline (1–10 nM) is able to enhance platelet activation evoked by subthreshold collagen (150 ng/ml), resulting in augmentation of platelet aggregation, thrombus formation under arterial flow conditions, platelet PS exposure, and formation of platelet-fibrin clots. The development of platelet procoagulant response evoked by adrenaline + low collagen was associated with the formation of denser platelet-fibrin clots and the decrease in rate of fibrinolysis despite whether lysis was initiated inside (internal fibrinolysis) or outside the clot (external fibrinolysis). The above phenomena were abolished by the α2-adrenergic receptor antagonist, rauwolscine. Adrenaline-collagen synergism, expressed as PS exposure, was significantly reduced by cyclooxygenase inhibitor (acetylsalicic acid), GPIIb/IIIa receptor blocker (tirofiban), and P2Y12 receptor antagonist (PSB 0739). Conclusion: Clinically relevant concentrations of adrenaline may significantly augment responses of human platelets in the presence of subthreshold concentrations of collagen, which should be considered during therapies involving adrenaline infusion. Routinely used antiplatelet drugs may reduce the prothrombotic state evoked by adrenaline-collagen synergism.
No takes yet. Share an insight, caveat, or question.
Gołaszewska et al. (2021) studied Healthy. Adrenaline vs. Control (no adrenaline) was evaluated on Platelet procoagulant response and thrombus formation. Clinically relevant concentrations of adrenaline (1-10 nM) significantly augmented human platelet activation, thrombus formation, and procoagulant responses in the presence of subthreshold collagen, and attenuated fibrinolysis.
Synapse has enriched 10 related papers. Consider them for comparative context: